Home Equities Letter to the Investment Committee on Private Equity – GMO – Commentaries
Equities

Letter to the Investment Committee on Private Equity – GMO – Commentaries

Share


Executive Summary

Some institutional investors who had grown accustomed to outperforming the broader private equity composites are finding they have not done so consistently in recent years. Their diagnoses of the problem often center on specific decisions or biases they made in their recent manager selection, whereas a likely culprit is a falloff in the persistence of outperformance among private equity managers.

While wide performance dispersion persists among private equity funds of a given vintage, academic research suggests that the tendency for a manager’s prior strong performance to persist into subsequent funds has largely disappeared, particularly when prior performance is based on the interim measures used to compare funds less than 10–15 years old. If this lack of persistence is the “new normal,” it will be very difficult for investors to expect to outperform the private equity composites by meaningful amounts going forward.

Investment committees should encourage institutions to raise the bar for hiring private equity managers, as putting money to work relatively cheaply in the public markets is a better investment than paying high fees for private equity managers they have less than full confidence in.

Read Part 1 of the Quarterly Letter, What Barbarians Like to Take Private (Or: The Risks in Your Private Equity Portfolio), in which Ben Inker and John Pease use decades of buyout data to demonstrate how private equity portfolios are becoming ever more concentrated on a small set of risks.

My day job at GMO does not directly involve private equity beyond being an observer. But I do wind up discussing private equity reasonably regularly, both with investment committees that I serve on and when invited to speak to the investment committees of other institutions. And in those situations, I’ve started to notice something a little jarring that may not be as obvious to investment committee members who only experience the performance of one or two institutions.

It is well known that private equity has failed to keep up with the public markets over the last several years. But I also seem to be hearing from a number of institutions that the performance of their particular PE portfolio, which in the past might have done substantially better than the Preqin, Cambridge Associates, or other composite, no longer seems to be doing so. There is usually an excuse that feels specific to the institution in question—“we focused too much on co-investment opportunities and failed to keep a high enough bar on our expectations for the actual fund performance,” or “we were too slow to react to our GPs’ loss of focus and mission creep.”



Source link

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

1 Spectacular Growth Stock to Buy Before It Soars by as Much as 124%, According to Wall Street

Sea Limited (NYSE: SE) is a triple threat in the digital economy....

The Magnum Ice Cream Company: Still Cheap Amid Rumored Private Equity Interest (NYSE:MICC) – Seeking Alpha

The Magnum Ice Cream Company: Still Cheap Amid Rumored Private Equity Interest...

Why ASML Holding N.V. (ASML) is One of the Best Oversold Growth Stocks to Invest in Now

ASML Holding N.V. (NASDAQ:ASML) is one of the best oversold growth stocks...

Ares Management’s SWOT analysis: stock navigates growth amid earnings challenges By Investing.com

Ares Management Corporation (), a leading global alternative asset manager with a...